Understanding Chronic Graft-vs.-Host Disease

Explore the guiding principles of identifying and treating chronic graft-vs.-host disease. Learn about how this serious complication of transplant can manifest in different organs, as well as the AP's role in its management.

Funding provided by an unrestricted educational grant from Kadmon, a Sanofi Company, and Pharmacyclics, an AbbVie Company, and Janssen Biotech, Inc.



Click the button below to download the Educator Module slide deck and presenter notes.


Download